Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats
Chem Rev 121:32973351 White BH, Whalen K, Kriksciukaite K, Alargova R, Au Yeung T, Bazinet P, Brockman A, DuPont M, Oller H et al (2019) Discovery of an SSTR2-targeting maytansinoid conjugate (PEN-221) with potent activity in vitro and in vivo
however, no change in medication or dose was allowed
Support your therapy with lifestyle changes like eating sulfur-rich foods and managing stress levels
Power is still power, but nature briefly levels the scene: everyone is being handled by the same force
Editors note: This article originally appeared in Perio-Implant Advisory , a chairside resource for dentists and hygienists that focuses on periodontal- and implant-related issues